Terms: = Endocrine gland cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
454 results:
1. CLIP170 inhibits the metastasis and emt of papillary thyroid cancer through the TGF-β pathway.
Ma B; Xu Y; Gao H; Yang Y; Pan Y; You C
Med Oncol; 2024 May; 41(6):137. PubMed ID: 38705933
[TBL] [Abstract] [Full Text] [Related]
2. Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
Kong D; Wu Y; Liu Q; Huang C; Wang T; Huang Z; Gao Y; Li Y; Guo H
Eur J Med Res; 2024 Apr; 29(1):231. PubMed ID: 38609993
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA
Wei Y; Zhu P
Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
[TBL] [Abstract] [Full Text] [Related]
4. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
5. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning developed a CD8
Chen R; Zheng Y; Fei C; Ye J; Fei H
Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
[TBL] [Abstract] [Full Text] [Related]
7. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S
Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098
[TBL] [Abstract] [Full Text] [Related]
8. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
9. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway.
Wang H; Xu YH; Guo Y
J Ovarian Res; 2024 Feb; 17(1):50. PubMed ID: 38395907
[TBL] [Abstract] [Full Text] [Related]
10. CD73 mitigates ZEB1 expression in papillary thyroid carcinoma.
Vedovatto S; Oliveira FD; Pereira LC; Scheffel TB; Beckenkamp LR; Bertoni APS; Wink MR; Lenz G
Cell Commun Signal; 2024 Feb; 22(1):145. PubMed ID: 38388432
[TBL] [Abstract] [Full Text] [Related]
11. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
Joseph AM; Al Aiyan A; Al-Ramadi B; Singh SK; Kishore U
Front Immunol; 2024; 15():1323198. PubMed ID: 38384463
[TBL] [Abstract] [Full Text] [Related]
12. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
Dang C; Bian Q; Wang F; Wang H; Liang Z
Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
[TBL] [Abstract] [Full Text] [Related]
14. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract] [Full Text] [Related]
15. AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
Ju G; Xing T; Xu M; Zhang X; Sun Y; Mu Z; Sun D; Miao S; Li L; Liang J; Lin Y
Neoplasia; 2024 Mar; 49():100972. PubMed ID: 38237535
[TBL] [Abstract] [Full Text] [Related]
16. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
Chen X; Shen H; Liu H; Tan L; Zhang N
Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
[TBL] [Abstract] [Full Text] [Related]
17. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract] [Full Text] [Related]
18. Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients.
Gao Y; Qi Y; Shen Y; Zhang Y; Wang D; Su M; Liu X; Wang A; Zhang W; He C; Yang J; Dai M; Wang H; Cai H
Aging (Albany NY); 2024 Jan; 16(1):207-225. PubMed ID: 38175687
[TBL] [Abstract] [Full Text] [Related]
19. β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway.
Shen J; Ma X; Wei Z; Qian Q; Jing A; Ding Y; Geng T; Qin J; Ma L; Chen Y; Ji J; Liu B; Huang J
Mol Cell Endocrinol; 2024 Mar; 582():112127. PubMed ID: 38109990
[TBL] [Abstract] [Full Text] [Related]
20. Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
[Next]